HAL (France)open access
Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool
PREDICT tool, 0, Adjuvant treatment, Genomic signature, EndoPredict®, Breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 350761
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.